Conference Coverage

Abortion restrictions linked to less evidence-based care for miscarriages


 

AT ACOG 2023

Institutional policies had the strongest impact

Before accounting for the state a hospital was in, 27% of institutions with restrictive abortion policies looked at more than imaging in determining how to proceed, compared with 88% of institutions without abortion restrictions that included clinical judgment and patient preferences in their management.

After controlling for state policies and affiliation with a family planning training program or a religious entity, the odds of an institution relying solely on imaging guidelines were over 12 times greater for institutions with abortion restrictions or bans (odds ratio, 12.3; 95% confidence interval, 3.2-47.9). Specifically, the odds were 9 times greater for institutions with restrictions and 27 times greater for institutions with bans.

Only 12% of the institutions without restrictions relied solely on ultrasound criteria, compared with 67% of the institutions with restrictions and 82% of the institutions that banned all abortions except to save the life of the pregnant individual (P < .001).

Only one in four (25%) of the programs with institutional abortion restrictions used mifepristone, compared with 86% of unrestricted programs (P < .001), and 40% of programs with institutional abortion restrictions used office-based aspiration, compared with 81% of unrestricted programs (P < .001).

Without access to all evidence-based treatments, doctors are often forced to choose expectant management for miscarriages. “So you’re kind of forced to have them to pass the pregnancy at home, which can be traumatic for patients” if that’s not what they wanted, Dr. Phillips said.

Dr. Flink-Bochacki further noted that this patient population is already particularly vulnerable.

“Especially for patients with early pregnancy loss, it’s such a feeling of powerlessness already, so the mental state that many of these patients are in is already quite fraught,” Dr. Flink-Bochacki said. “Then to not even have power to choose the interventions that you want or to be able to access interventions in a timely fashion because you’re being held to some arbitrary guideline further takes away the power and further exacerbates the trauma of the experience.”

The biggest factor likely driving the reduced access to those interventions is the fear that the care could be confused with providing an abortion instead of simply managing a miscarriage, Dr. Flink-Bochacki said. “I think that’s why a lot of these programs don’t have mifepristone and don’t offer outpatient uterine aspiration,” she said. “Because those are so widely used in abortion and the connotation is with abortion, they’re just kind of steering clear of it, but meanwhile, patients with pregnancy loss are suffering because they’re being unnecessarily restrictive.”

The research did not use any external funding, and the authors and Dr. Heuser had no disclosures.

Pages

Recommended Reading

Access to abortion clinics declines sharply
Journal of Clinical Outcomes Management
Physicians react: Climate change and other social issues
Journal of Clinical Outcomes Management
Post-birth hospitalizations dropped with Medicaid expansion
Journal of Clinical Outcomes Management
COVID dramatically increases death risk during pregnancy: Study
Journal of Clinical Outcomes Management
Maternal COVID-19 vaccine curbs infant infection
Journal of Clinical Outcomes Management
Scientists create ‘vagina on a chip’: What to know
Journal of Clinical Outcomes Management
Doctors are disappearing from emergency departments as hospitals look to cut costs
Journal of Clinical Outcomes Management
New state bill could protect docs prescribing abortion pills to out-of-state patients
Journal of Clinical Outcomes Management
COVID led to rise in pregnancy-related deaths: New research
Journal of Clinical Outcomes Management
Over half of pregnant patients not properly screened for thyroid disease
Journal of Clinical Outcomes Management